The novel treatment did not meet primary endpoints, however it did reduce hospitalization, adverse outcomes, and death.
Women with pregnancy at an advanced age had significantly higher rates of ischemic stroke, hemorrhagic stroke, myocardial infarction, and cardiovascular death.
Patients of advanced age, black race, and with comorbidities have a higher risk of post-stroke GIBO.
The average annual cost for providing care to a stroke survivor was $11,300.
REVERSE-AD is an ongoing phase 3 cohort study evaluating the reversal effects of idarucizumab on dabigatran.
Treatment with IV tPA appeared safe and feasible with stroke onset confirmation from MRI.
Improvements in Rankin Scale score, Stroke Impact Scale-16, and Montreal Cognitive Assessment were observed in the treatment group.
Some strokes attributable to large-artery atherosclerosis are not being recognized as such because of <50% stenosis.
Those who slept more than 8 hours had a 146% greater risk of stroke.
Patients taking pioglitazone saw a 24% reduction in risk for recurrent stroke or myocardial infarction compared to placebo.
The risk among people with migraine with aura was especially high for cardioembolic stroke.
Surprisingly, multiple types of stroke were associated with a greater risk of seizure than TBI.
The authors speculate that women may have pre-stroke functional deficits, and minorities may have poorer access to care.
Dr Albert Favate addresses some of the hottest topics concerning stroke care and patient management.
Over 20% of women currently on HRT saw an increase in migraine severity.
The guidelines recommend that physicians be specially trained in endovascular neurosurgery in order to perform the procedure.
All is not lost for patients presenting with severe stroke beyond the 6-hour mark.
Time to treatment for ischemic stroke is critical and directly affects functional outcomes.
The long-term benefits of endovascular thrombectomy appear to offset the costs of the procedure.
Neurology Advisor Articles
- Multiple System Atrophy: A Common Form of Atypical Parkinsonism
- Migraine Treatment in the ED: Overcoming Our Penchant for Opioids
- Erenumab as a Therapy for Hard to Treat Episodic Migraine
- Nusinersen May Be Effective for Short-Term Motor Function Improvements in Spinal Muscular Atrophy
- Reduced Survival for Patients With Idiopathic Parkinsonism
- New Diagnostic Criteria for Neurosarcoidosis: What You Need to Know
- Guideline for Diagnosis and Treatment of Idiopathic Intracranial Hypertension
- Guidelines on the Use of OnabotulinumtoxinA for Chronic Migraine
- Ivy League Rule Change Linked to Fewer Concussions During NCAA Football Games
- Biomarkers of Alzheimer Disease Observed in Down Syndrome
- Short Segment Sensory Nerve Stimulation Offers Potential Diagnostic Value for Ulnar Neuropathy
- Incidence of Guillain-Barré Syndrome Linked With Recent Bone, Digestive Organ Surgery
- Online Tool Helps Patients With Advance Care Planning
- FDA Proposes New Restrictions on Sale of Electronic Nicotine Delivery Systems
- FDA Issues Safety Alert Regarding Intrathecal Delivery of Pain Meds